ESMO Congress provides forum for presentation of new research on treatment of cancer

Cancer is a leading cause of mortality worldwide, accounting for more than one in ten deaths. By 2030, the global burden is expected to exceed 12 million. The ESMO Congress provides a major international forum for the presentation of new research on the treatment of cancer

Congress Program Highlights
•    New findings from major Phase III trials, potentially practice changing
•    Promising new drugs to treat ovarian, skin, colorectal and other cancers
•    New hormonal agents in advanced prostate cancer
•    Personalized medicine: do ethnic differences matter?
•    Progress in the treatment of advanced colorectal cancer
•    Prevention and management of toxicity and other side-effects in targeted therapies
•    How proteomic profiling can guide therapy selection
•    The importance of conducting well-designed clinical trials
•    Combining chemotherapy and radiotherapy in small cell lung cancer
•    New developments in targeted therapies for lung cancer
•    MicroRNAs: the new genes involved in cancer
•    European disparities in cancer control

•    More than 200 presentations; more than 300 international experts
•    Late-breaking abstracts: the latest studies with new findings

•    NEW! Multidisciplinary Interactive Sessions (MIS): experts will present treatment options from the perspective of different disciplines within a multidisciplinary team.
•    Controversy sessions: five lively discussions on particularly hot topics based on latest research results.
•    Keynote Lectures: three important presentations in the field of basic science and translational research, the new frontier in cancer research.
•    The seventh batch of ESMO Designated Centers of Integrated Oncology and Palliative Care will be announced as centers of excellence for patient care in Europe.
•    A session on the newly released ESMO Clinical Practice Guidelines: the best standards of cancer care with improved methodology.
•    Oncology Highlights of the most important advances in cancer treatment in 2010.

•    The 8th ESMO Patient Seminar where patients will have the chance to meet oncologists and hear about the conditions of cancer treatment in Europe, discuss and confront doctors about the consequences of cancer therapy, learn the approaches to long-term survivorship and the future perspective of cancer treatments.

The conference full program is available at http://www.esmo.org/events/milan-2010-congress/program.html

Meeting venue
The 35th ESMO Congress will take place at Fiera Milano Congressi, (viale Scarampo,20145 Milan, Italy), easily accessible by public transportation. You can take Metro line 1 (red) --direction to Rho Fiera, stop at Lotto Fieramilanocity station. Follow the Exit 'via Vigliani'.

Appointments for the Media
Friday, 8 October 2010

Opening Press Conference
12:00-13:00, Press Conference Room (Asia Room)

Saturday, 9 October 2010

Press Briefing Day 1
8:15-9:00, ESMO Press Conference Room (Asia Room)
Gynaecological cancers, Chest tumours, Palliative Care

Round-table
12:00-12:45, Press Conference Room (Asia Room)
Topic to be confirmed

Sunday, 10 October 2010

Press Briefing Day 2
8:15-9:00, Press Conference Room (Asia Room)
Breast cancer, Neuro-oncology, Hematological malignancies

Press Conference
12:15-13:00, Press Conference Room (Asia Room)
Topic to be confirmed

Monday, 11 October 2010

Press Briefing Day 3
8:15-9:00, Press Conference Room (Asia Room)
Breast cancer, Chest tumours, Gynaecological cancers

Round-table
12:15-13:00, Press Conference Room (Asia Room)
Topic to be confirmed

http://www.esmo.org/events/milan-2010-congress.html

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows cannabis as a genotoxic substance with cancer risks